Trv Gp III, LLC
10% owner at Jounce Therapeutics, Inc.; 10% owner at Global Blood Therapeutics, Inc.
- Sold, on record
- $68.2M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Nov 12, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Jounce Therapeutics, Inc.10% owner
- Global Blood Therapeutics, Inc.10% owner
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- Global Blood Therapeutics, Inc.2M shares
- Jounce Therapeutics, Inc.1.9M shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Global Blood Therapeutics, Inc.UnusualMar 2, 2017 2017
Sold 2M shares at $25.54 ($52.2M)
Trv Gp III, LLC, 10% owner
Sold 93.3% of holdings ($56M position)146,208 shares leftFirst sale on recordFiling
- 2 Form 4 sale Jounce Therapeutics, Inc.UnusualNov 12, 2021 +1716 days
Sold 1.9M shares at $8.38 ($15.9M)
Trv Gp III, LLC, 10% owner
Sold 62.3% of holdings ($25.5M position)1.1M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2021 | Nov 16, 2021 | Jounce Therapeutics, Inc. | 10% owner | Form 4 sale | 1.9M | $15.9M | 62.3% | Unusual | SEC |
| Mar 2, 2017 | Mar 6, 2017 | Global Blood Therapeutics, Inc. | 10% owner | Form 4 sale | 2M | $52.2M | 93.3% | Unusual | SEC |